Henkel Joins with MedTech Europe to Drive Innovation In the Medical Technology Industry

Henkel, a leading global provider of adhesives, sealants and functional coatings, today announced its membership with MedTech Europe, the industry association representing the medical technology sector in Europe. This collaboration aims to foster innovation and promote sustainable development in the value chains supporting the medical technology industry.

Henkel has a long history of supporting the medical technology industry with its advanced adhesive and surface solutions. Through this, Henkel and MedTech Europe will collaborate on various initiatives such as supporting research and development projects, driving thought leadership and engaging in industry forums. The goal is to accelerate the adoption of innovative solutions, address industry challenges, and contribute to advancing the medical technology sector.

The partnership with MedTech Europe is part of the company’s broader strategy to strengthen its collaborations within the healthcare industry and ecosystem. By collaborating with industry associations, healthcare organizations, and technology providers, Henkel aims to drive innovation and create value for patients, healthcare professionals, and its partners throughout value chains.

“Joining forces with MedTech Europe is an exciting step for us. Together, we will be able to leverage our combined expertise to develop innovative solutions that address the ever-evolving needs of the medical technology industry,” said Dr. Philipp Loosen, Vice President and Head of Industrials EIMEA and Global Key Accounts Medical at Henkel Adhesive Technologies. “MedTech Europe represents the medical technology industry in Europe, covering a wide range of products, including medical devices, diagnostics, imaging equipment, and more.”

Chemical regulatory compliance is important to Henkel, and MedTech Europe provides multiple platforms to collaborate, contribute, and advocate the same through their working groups that deep dive into the aspects of sustainability, chemicals, and medical device regulations. “This is another milestone on our journey to becoming the key player in chemical regulatory compliance for our medical customers that contributes to sustainability and the environment,” said Senthil Pichandi, Vice President Global Product Safety and Regulatory Affairs (PSRA), Henkel Adhesive Technologies.

More here.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”